5-[5-fluoro-6-(piperidin-3-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one
C19H24F4N4O2 — CID 154825714
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[5-fluoro-6-(piperidin-3-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one
5-[5-fluoro-6-(piperidin-3-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one (PubChem CID 154825714) has the molecular formula C19H24F4N4O2 and a molecular weight of 416.42 g/mol. Its IUPAC name is 5-[5-fluoro-6-(piperidin-3-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one.
Molecular Properties
| Compound Name | 5-[5-fluoro-6-(piperidin-3-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one |
|---|---|
| PubChem CID | 154825714 |
| Molecular Formula | C19H24F4N4O2 |
| Molecular Weight | 416.42 g/mol |
| Exact Mass | 416.18 |
| IUPAC Name | 5-[5-fluoro-6-(piperidin-3-ylmethoxy)-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one |
| SMILES | O=C1NNCC(N2Cc3cc(F)c(OCC4CCCNC4)cc3C2)C1C(F)(F)F |
| InChI | InChI=1S/C19H24F4N4O2/c20-14-4-12-8-27(15-7-25-26-18(28)17(15)19(21,22)23)9-13(12)5-16(14)29-10-11-2-1-3-24-6-11/h4-5,11,15,17,24-25H,1-3,6-10H2,(H,26,28) |
| InChIKey | LEGBWPVQSOWGHE-UHFFFAOYSA-N |
| XLogP | 1.70 |
| TPSA | 65.63 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 416.42 |
| LogP ≤ 5 | 1.70 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154825714 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.